Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2015:2015:684025.
doi: 10.1155/2015/684025. Epub 2015 Mar 24.

The bipolar depression electrical treatment trial (BETTER): design, rationale, and objectives of a randomized, sham-controlled trial and data from the pilot study phase

Affiliations
Free PMC article
Case Reports

The bipolar depression electrical treatment trial (BETTER): design, rationale, and objectives of a randomized, sham-controlled trial and data from the pilot study phase

Bernardo de Sampaio Pereira Junior et al. Neural Plast. 2015.
Free PMC article

Abstract

Background: Bipolar depression (BD) is a prevalent condition, with poor therapeutic options and a high degree of refractoriness. This justifies the development of novel treatment strategies, such as transcranial direct current stimulation (tDCS) that showed promising results in unipolar depression.

Methods: We describe a randomized, sham-controlled, double-blinded trial using tDCS for refractory, acutely symptomatic BD (the bipolar depression electrical treatment trial, BETTER). Sixty patients will be enrolled and assessed with clinical and neuropsychological tests. The primary outcome is change (over time and across groups) in the scores of the Hamilton Depression Rating Scale (17 items). Biological markers such as blood neurotrophins and interleukins, genetic polymorphisms, heart rate variability, and motor cortical excitability will be assessed. Twelve anodal-left/cathodal-right 2 mA tDCS sessions over the dorsolateral prefrontal cortex will be performed in 6 weeks.

Results: In the pilot phase, five patients received active tDCS and were double-blindly assessed, two presenting clinical response. TDCS was well-tolerated, with no changes in cognitive scores.

Conclusion: This upcoming clinical trial will address the efficacy of tDCS for BD on different degrees of refractoriness. The evaluation of biological markers will also help in understanding the pathophysiology of BD and the mechanisms of action of tDCS.

PubMed Disclaimer

Figures

Figure 1
Figure 1
MADRS scores for each patient (pilot phase).
Figure 2
Figure 2
YMRS scores for each patient (pilot phase).
Figure 3
Figure 3
HDRS scores for each patient (pilot phase).

Similar articles

Cited by

References

    1. Geddes J. R., Miklowitz D. J. Treatment of bipolar disorder. The Lancet. 2013;381(9878):1672–1682. doi: 10.1016/S0140-6736(13)60857-0. - DOI - PMC - PubMed
    1. Judd L. L., Akiskal H. S., Schettler P. J., et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Archives of General Psychiatry. 2002;59(6):530–537. doi: 10.1001/archpsyc.59.6.530. - DOI - PubMed
    1. Judd L. L., Akiskal H. S., Schettler P. J., et al. A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Archives of General Psychiatry. 2003;60(3):261–269. doi: 10.1001/archpsyc.60.3.261. - DOI - PubMed
    1. Henin A., Mick E., Biederman J., et al. Is psychopharmacologic treatment associated with neuropsychological deficits in bipolar youth? The Journal of Clinical Psychiatry. 2009;70(8):1178–1185. doi: 10.4088/jcp.08m04696. - DOI - PubMed
    1. Velligan D. I., Weiden P. J., Sajatovic M., et al. The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness. The Journal of Clinical Psychiatry. 2009;70(supplement 4):1–48. - PubMed

Publication types